Neuroprotective dose and safety profile of magnesium sulphate therapy in term neonates with perinatal asphyxia
Journal Title: Pediatric Review: International Journal of Pediatric Research - Year 2016, Vol 3, Issue 2
Abstract
Introduction: Perinatal asphyxia has become a major public health problem accounting for 9% of total under-5 mortality. It can lead to serious neuro-motor sequelae in survivors. Newer neuroprotective strategies for management of perinatal asphyxia have gained momentum in recent era. Background: To determine the effective dosage regimen and safety profile of intravenous magnesium sulphate as a neuroprotective agent for perinatal asphyxia in term neonates. Materials and methods: 60 term asphyxiated neonates admitted in NICU of a tertiary care teaching hospital were evaluated. Babies were treated as per the standard treatment protocol for perinatal asphyxia. The infants received 250 mg/kg per dose intravenous magnesium over 1 hour within 6 hrs of birth, with 2 additional doses repeated at intervals of 24 hours. The heart rate, respiratory rate, blood pressure and oxygen saturation were monitored continuously. A baseline serum magnesium level was measured soon after delivery and two more serum magnesium levels at 24 hr and at 48 hr was measured. Results: The pre intervention baseline serum magnesium level was 1.52 (±0.302) meq/L. The serum magnesium level increased from the baseline level of 1.52 (±0.302) meq/L to 2.63 (±0.558) meq/L at 24 hour and 2.72 (±0.495) meq/L at 48 hour. The neuroprotective range of serum magnesium is 2.4 – 5 Meq/L. This dosage regimen will ensure plasma concentration of magnesium in the neuroprotective range for 48 hours. All physiologic variables remained unchanged including heart rate, respiratory rate, blood pressure and oxygen saturation during intervention. Conclusion: Intravenous infusion of 3 doses of magnesium 250 mg/kg/dose in first 48 hrs after birth will ensure serum magnesium level in the neuroprotective range. This therapeutic dosage regimen has been found to have the best margin of safety profile in term asphyxiated infants.
Authors and Affiliations
Raj Prakash
Keywords
Related Articles
- EP ID EP223340
- DOI 10.17511
- Views 148
- Downloads 0
Congenital adrenal hyperplasia in a male neonate presenting as unresponsive sepsis
Congenital Adrenal Hyperplasia (CAH) is a disease of Adrenal steroid synthesis. Classic congenital adrenal hyperplasia (CAH) due to 21 hydroxylase deficiency results in one of two clinical syndromes: a salt-losing form o...
Extra-Hepatic portal venous obstruction with portal biliopathy in infant presenting as neonatal cholestasis: a rare case report and review of literature
Extra-hepatic portal venous obstruction is most common cause of portal hypertension in children. Apart from variceal formation in gastric and esophageal mucosal layer, it has been postulated that external pressure and or...
Outcome analysis of intussusception in fifty children at a tertiary centre in Mumbai
Background: Intussusception is a common cause of obstruction in Paediatric patients. Recognizing and treating this condition rapidly is important to prevent potentially fatal complications. Methods: Fifty consecutive pat...
An incidental finding of a vegetative foreign body in left main bronchus in a child presented as wheeze associated respiratory tract infection
Foreign body aspiration is an important cause of pediatric morbidity and mortality, particularly in children between the age of 6 months and five years. It is potentially life threatening event and may also cause chronic...
A study on clinico-epidemiological profile of typhoid fever in a rural based medical college & hospital; West Bengal; India
Introduction: Typhoid fever is estimated to have caused 26.9 million cases and 5.74 lakhs deaths worldwide in 2010. It remains a major public health problem in India and other part of developing world. Background: Nonpro...